Literature DB >> 19567251

ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays.

Yifang Hu1, Gordon K Smyth.   

Abstract

ELDA is a software application for limiting dilution analysis (LDA), with particular attention to the needs of stem cell assays. It is the first limiting dilution analysis software to provide meaningful confidence intervals for all LDA data sets, including those with 0% or 100% responses. Other features include a test of the adequacy of the single-hit hypothesis, tests for frequency differences between multiple data sets, and the ability to take advantage of cases where the number of cells in the sample is counted exactly. A webtool at http://bioinf.wehi.edu.au/software/elda/ provides an easy user interface.

Mesh:

Year:  2009        PMID: 19567251     DOI: 10.1016/j.jim.2009.06.008

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  917 in total

1.  Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival.

Authors:  Qiao Zheng; Sarah M Dunlap; Jinling Zhu; Erinn Downs-Kelly; Jeremy Rich; Stephen D Hursting; Nathan A Berger; Ofer Reizes
Journal:  Endocr Relat Cancer       Date:  2011-07-11       Impact factor: 5.678

2.  MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells.

Authors:  Yingjie Yu; Shailender S Kanwar; Bhaumik B Patel; Phil-Sun Oh; Jyoti Nautiyal; Fazlul H Sarkar; Adhip P N Majumdar
Journal:  Carcinogenesis       Date:  2011-11-09       Impact factor: 4.944

3.  Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14.

Authors:  Marie-Liesse Asselin-Labat; Kate D Sutherland; François Vaillant; David E Gyorki; Di Wu; Sheridan Holroyd; Kelsey Breslin; Teresa Ward; Wei Shi; Mary L Bath; Siddhartha Deb; Stephen B Fox; Gordon K Smyth; Geoffrey J Lindeman; Jane E Visvader
Journal:  Mol Cell Biol       Date:  2011-09-19       Impact factor: 4.272

4.  Evidence for label-retaining tumour-initiating cells in human glioblastoma.

Authors:  Loic P Deleyrolle; Angus Harding; Kathleen Cato; Florian A Siebzehnrubl; Maryam Rahman; Hassan Azari; Sarah Olson; Brian Gabrielli; Geoffrey Osborne; Angelo Vescovi; Brent A Reynolds
Journal:  Brain       Date:  2011-04-22       Impact factor: 13.501

5.  A mammary stem cell population identified and characterized in late embryogenesis reveals similarities to human breast cancer.

Authors:  Benjamin T Spike; Dannielle D Engle; Jennifer C Lin; Samantha K Cheung; Justin La; Geoffrey M Wahl
Journal:  Cell Stem Cell       Date:  2012-02-03       Impact factor: 24.633

6.  A rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potential.

Authors:  Chung-Gi Lee; Bikul Das; Tara L Lin; Chelsea Grimes; Xin Zhang; Tracey Lavezzi; Li Huang; John Cole; Lillian Yau; Li Li
Journal:  Br J Haematol       Date:  2012-04-18       Impact factor: 6.998

7.  Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly.

Authors:  Anandharaman Veerapathran; Joseph Pidala; Francisca Beato; Xue-Zhong Yu; Claudio Anasetti
Journal:  Blood       Date:  2011-09-23       Impact factor: 22.113

8.  Radioresistance mechanisms of mammary tumor initiating cells: unreliable biological conclusions based on limiting dilution assays.

Authors:  Thierry Bonnefoix; Mary Callanan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-05       Impact factor: 11.205

9.  OKT3 prevents xenogeneic GVHD and allows reliable xenograft initiation from unfractionated human hematopoietic tissues.

Authors:  Mark Wunderlich; Ryan A Brooks; Rushi Panchal; Garrett W Rhyasen; Gwenn Danet-Desnoyers; James C Mulloy
Journal:  Blood       Date:  2014-04-28       Impact factor: 22.113

10.  Fibroblast growth factor receptor signaling is essential for normal mammary gland development and stem cell function.

Authors:  Adam C Pond; Xue Bin; Torey Batts; Kevin Roarty; Susan Hilsenbeck; Jeffrey M Rosen
Journal:  Stem Cells       Date:  2013-01       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.